couple dealing with depression

NeuraWell Therapeutics

Clinical Stage
Research & Development
Company Focused
On CNS Disorders

Our mission is to offer CNS treatments that reliably deliver meaningful therapeutic responses with enhanced safety,  to fill an unmet need where other treatments have failed.

Targeted Disorders

Future Research


Major Depressive Disorder (MDD)
Treatment Resistant Depression (TRD)

More About Patient Needs


Treatment Resistant Anxiety

More About Patient Needs

Additional future development opportunities include neurological conditions such as Parkinson’s disease and seizure disorders.

Our Approach

Pharmacology & Technology

NeuraWell utilizes a combination of pharmacology that coincides with an advanced technical patient application

Our Approach